BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16267282)

  • 1. Adenylate cyclase toxin (ACT) from Bordetella hinzii: characterization and differences from ACT of Bordetella pertussis.
    Donato GM; Hsia HL; Green CS; Hewlett EL
    J Bacteriol; 2005 Nov; 187(22):7579-88. PubMed ID: 16267282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.
    Hewlett EL; Gray MC; Ehrmann IE; Maloney NJ; Otero AS; Gray L; Allietta M; Szabo G; Weiss AA; Barry EM
    J Biol Chem; 1993 Apr; 268(11):7842-8. PubMed ID: 8385122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Pertussis and Adenylate Cyclase Toxins by Sigma Factor RpoE in Bordetella pertussis.
    Barbier M; Boehm DT; Sen-Kilic E; Bonnin C; Pinheiro T; Hoffman C; Gray M; Hewlett E; Damron FH
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli.
    Glaser P; Ladant D; Sezer O; Pichot F; Ullmann A; Danchin A
    Mol Microbiol; 1988 Jan; 2(1):19-30. PubMed ID: 2897067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system.
    Sebo P; Glaser P; Sakamoto H; Ullmann A
    Gene; 1991 Jul; 104(1):19-24. PubMed ID: 1916273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Eukaryotic Host Factor 14-3-3 Inactivates Adenylate Cyclase Toxins of Bordetella bronchiseptica and B. parapertussis, but Not B. pertussis.
    Fukui-Miyazaki A; Toshima H; Hiramatsu Y; Okada K; Nakamura K; Ishigaki K; Shinzawa N; Abe H; Horiguchi Y
    mBio; 2018 Aug; 9(4):. PubMed ID: 30154257
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9.
    Havlícek V; Higgins L; Chen W; Halada P; Sebo P; Sakamoto H; Hackett M
    J Mass Spectrom; 2001 Apr; 36(4):384-91. PubMed ID: 11333441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis adenylate cyclase toxin: proCyaA and CyaC proteins synthesised separately in Escherichia coli produce active toxin in vitro.
    Westrop GD; Hormozi EK; Da Costa NA; Parton R; Coote JG
    Gene; 1996 Nov; 180(1-2):91-9. PubMed ID: 8973351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities.
    Sakamoto H; Bellalou J; Sebo P; Ladant D
    J Biol Chem; 1992 Jul; 267(19):13598-602. PubMed ID: 1618862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.
    Boyd AP; Ross PJ; Conroy H; Mahon N; Lavelle EC; Mills KH
    J Immunol; 2005 Jul; 175(2):730-8. PubMed ID: 16002668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive adenylate cyclase toxin of Bordetella pertussis.
    Hanski E
    Trends Biochem Sci; 1989 Nov; 14(11):459-63. PubMed ID: 2560273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of soluble expression in Escherichia coli and characterisation of the CyaA pore-forming fragment from a Bordetella pertussis Thai clinical isolate.
    Powthongchin B; Angsuthanasombat C
    Arch Microbiol; 2008 Feb; 189(2):169-74. PubMed ID: 17846749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis.
    Rogel A; Meller R; Hanski E
    J Biol Chem; 1991 Feb; 266(5):3154-61. PubMed ID: 1847141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis.
    Ehrmann IE; Gray MC; Gordon VM; Gray LS; Hewlett EL
    FEBS Lett; 1991 Jan; 278(1):79-83. PubMed ID: 1993477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
    Hormozi K; Parton R; Coote J
    Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylation of lysine 983 is sufficient for toxin activity of Bordetella pertussis adenylate cyclase. Substitutions of alanine 140 modulate acylation site selectivity of the toxin acyltransferase CyaC.
    Basar T; Havlícek V; Bezousková S; Hackett M; Sebo P
    J Biol Chem; 2001 Jan; 276(1):348-54. PubMed ID: 11031260
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Nash ZM; Inatsuka CS; Cotter PA; Johnson RM
    mBio; 2024 May; 15(5):e0063224. PubMed ID: 38534159
    [No Abstract]   [Full Text] [Related]  

  • 18. The adenylate cyclase toxin contributes to the survival of Bordetella pertussis within human macrophages.
    Masure HR
    Microb Pathog; 1993 Apr; 14(4):253-60. PubMed ID: 8392135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.
    Carbonetti NH
    Future Microbiol; 2010 Mar; 5(3):455-69. PubMed ID: 20210554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression.
    Carbonetti NH; Khelef N; Guiso N; Gross R
    J Bacteriol; 1993 Oct; 175(20):6679-88. PubMed ID: 8407844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.